Palo Alto, CA, United States of America

Huisheng Wang



 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 197(Granted Patents)


Location History:

  • Los Angeles, CA (US) (2009 - 2010)
  • Palo Alto, CA (US) (2012 - 2022)
  • Edison, NJ (US) (2018 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: **Innovator Spotlight: Huisheng Wang**

Introduction

Huisheng Wang, located in Edison, NJ, is an accomplished inventor with a focus on groundbreaking biomedical innovations. He has made significant contributions to the field of antibody research, particularly in the development of bispecific antibodies that have potential therapeutic applications.

Latest Patents

Wang holds two patents that showcase his expertise in creating antibodies specific for DR5 and FAP. His latest inventions include:

1. **Antibodies Specific for DR5 and Methods of Use** - This patent pertains to bispecific antibodies comprising at least one antigen-binding site specific for DR5 and at least one antigen-binding site specific for FAP. It details methods for their production, pharmaceutical compositions containing these antibodies, and their uses in treatment protocols.

2. **Bispecific Antibodies Specific for FAP and DR5** - Similar to the first, this patent highlights the innovation of bispecific antibodies targeting both DR5 and FAP, detailing production methods, applications, and therapeutic compositions.

Career Highlights

Huisheng Wang is currently associated with Roche Glycart AG, where he leverages his expertise to contribute to their research initiatives. His work is instrumental in advancing the development of novel therapies through innovative antibody technologies.

Collaborations

Wang collaborates with industry professionals including Peter Bruenker and Sherif Daouti. Together, they push the boundaries of research in antibody development and therapeutic applications, combining their unique skills and insights for greater advancements in the biomedical field.

Conclusion

Huisheng Wang embodies the spirit of innovation through his extensive work in antibody research. His patents not only contribute to the biotechnology industry but also have the potential to impact patient care significantly. As he continues his work with Roche Glycart AG, the medical community looks forward to the developments that will arise from his innovative approach.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…